X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-04 | NXL | Owens David | Chief Medical Officer | P - Purchase | $3.10 | +1,000 | 155,793 | +1% | +$3,100 | ||||||
2025-02-04 | NXL | Owens David | Chief Medical Officer | P - Purchase | $2.98 | +1,000 | 154,793 | +1% | +$2,980 | ||||||
2025-01-28 | NXL | Owens David | Chief Medical Officer | P - Purchase | $2.70 | +1,500 | 153,793 | +1% | +$4,050 | ||||||
| M | 2025-01-13 | NXL | Owens David | Chief Medical Officer | P - Purchase | $2.57 | +3,000 | 152,293 | +2% | +$7,700 | |||||
2024-10-28 | NXL | Owens David | Chief Medical Officer | P - Purchase | $2.19 | +500 | 148,293 | 0% | +$1,095 | ||||||
2024-08-13 | NXL | Owens David | Chief Medical Officer | P - Purchase | $0.95 | +1,000 | 147,793 | +1% | +$950 | ||||||
2024-06-28 | NXL | Owens David | Chief Medical Officer | P - Purchase | $1.75 | +1,000 | 146,793 | +1% | +$1,750 | ||||||
2024-06-18 | NXL | Owens David | Chief Medical Officer | P - Purchase | $0.71 | +1,619 | 145,793 | +1% | +$1,149 | ||||||
2024-06-10 | NXL | Owens David | Chief Medical Officer | P - Purchase | $0.64 | +3,000 | 144,174 | +2% | +$1,920 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |